165 related articles for article (PubMed ID: 8549613)
1. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.
Kehne JH; Baron BM; Harrison BL; McCloskey TC; Palfreyman MG; Poirot M; Salituro FG; Siegel BW; Slone AL; Van Giersbergen PL
Eur J Pharmacol; 1995 Sep; 284(1-2):109-18. PubMed ID: 8549613
[TBL] [Abstract][Full Text] [Related]
2. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
Baron BM; Harrison BL; McDonald IA; Meldrum BS; Palfreyman MG; Salituro FG; Siegel BW; Slone AL; Turner JP; White HS
J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
[TBL] [Abstract][Full Text] [Related]
4. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
Kehne JH; Kane JM; Miller FP; Ketteler HJ; Braun DL; Senyah Y; Chaney SF; Abdallah A; Dudley MW; Ogden AM
Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
[TBL] [Abstract][Full Text] [Related]
5. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.
Singh L; Donald AE; Foster AC; Hutson PH; Iversen LL; Iversen SD; Kemp JA; Leeson PD; Marshall GR; Oles RJ
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):347-51. PubMed ID: 2153294
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations.
Kehne JH; McCloskey TC; Baron BM; Chi EM; Harrison BL; Whitten JP; Palfreyman MG
Eur J Pharmacol; 1991 Feb; 193(3):283-92. PubMed ID: 1675993
[TBL] [Abstract][Full Text] [Related]
7. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
Komatsu H; Furuya Y; Sawada K; Asada T
Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
[TBL] [Abstract][Full Text] [Related]
11. Complex polyamine effects on [3H]MDL 105,519 binding to the NMDA receptor glycine site.
Sharma TA; Reynolds IJ
Neurochem Int; 1998 Aug; 33(2):155-9. PubMed ID: 9761459
[TBL] [Abstract][Full Text] [Related]
12. [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.
Baron BM; Siegel BW; Harrison BL; Gross RS; Hawes C; Towers P
J Pharmacol Exp Ther; 1996 Oct; 279(1):62-8. PubMed ID: 8858976
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation of the glutamate site on the NMDA receptor by four novel glycine site antagonists.
Grimwood S; Kulagowski JJ; Mawer IM; Rowley M; Leeson PD; Foster AC
Eur J Pharmacol; 1995 Aug; 290(3):221-6. PubMed ID: 7589216
[TBL] [Abstract][Full Text] [Related]
14. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
[TBL] [Abstract][Full Text] [Related]
15. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
16. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
17. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
[TBL] [Abstract][Full Text] [Related]
18. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
19. D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.
Schoepp DD; Smith CL; Lodge D; Millar JD; Leander JD; Sacaan AI; Lunn WH
Eur J Pharmacol; 1991 Oct; 203(2):237-43. PubMed ID: 1686860
[TBL] [Abstract][Full Text] [Related]
20. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
